| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |